EUROPE SEQUENCING REAGENTS MARKET 2021-2028

Description

MARKET OUTLOOK

CRI’s report on the sequencing reagents market states that the market in Europe is expected to thrive at a compound annual growth rate of 13.00% based on value during the projected period 2021-2028. Germany, Italy, Spain, France, Russia, the United Kingdom, and Rest of Europe shape the region’s market.
The United Kingdom is advancing its healthcare sector at a rapid pace. There is a surge in government initiatives, leading to a rise in R&D activities and an increase in specialized therapies relating to cancer and autoimmune diseases. Here, the growing prevalence of cancer is estimated to fuel the studied market’s growth. For instance, the country witnessed a rise in oncology, breast cancer, colorectal cancer, and skin melanoma in 2020. This surged the need for specialized therapies significantly, influencing the demand for sequencing reagents. Thus, these factors are expected to widen the scope and development of the sequencing reagents market.
On the other hand, the sequencing reagents market is likely to gain a significant share in Italy, owing to the high prevalence of chronic diseases, especially cancer. As per estimates, the country observed a substantial growth in oncology, breast cancer, and other cancer cases, which surged the need for sequencing reagents. Besides, the rising awareness relating to the benefits of sequencing reagents for cancer treatments has boosted the growth of the sequencing reagents market across the country to a large extent.

COMPETITIVE OUTLOOK

The major companies in the sequencing reagents market are Illumina Inc, Fluidigm Corporation, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Takara Bio Inc, Asuragen Inc, and Merck KGAA

TABLE OF CONTENTS

1. EUROPE SEQUENCING REAGENTS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING
3. EUROPE SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS
4. EUROPE SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES
5. EUROPE SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING
6. EUROPE SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS
7. EUROPE SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. GERMANY
7.1.2. FRANCE
7.1.3. THE UNITED KINGDOM
7.1.4. ITALY
7.1.5. RUSSIA
7.1.6. SPAIN
7.1.7. REST OF EUROPE
8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES
TABLE 1: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: EUROPE SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: EUROPE SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: EUROPE SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: EUROPE SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: EUROPE SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: EUROPE SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: GERMANY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: FRANCE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: UNITED KINGDOM SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: ITALY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: RUSSIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: SPAIN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)